Sarepta Therapeutics is paying Arrowhead Pharmaceuticals $500 million in cash, plus a $325 million equity investment, for worldwide licensing rights to seven programs—four clinical and three ...
(RTTNews) - Sarepta Therapeutics, Inc. (SRPT), Tuesday announced a global licensing and collaboration agreement with Arrowhead Pharmaceuticals, Inc. (ARWR) for multiple clinical, pre-clinical ...
(RTTNews) - Arrowhead Pharmaceuticals (ARWR), a clinical-stage biotech company, announced, on Tuesday, that it has entered into a global licensing and collaboration agreement with Sarepta ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback